BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 20, 2006
View Archived Issues
FDA Approves Herceptin In Adjuvant Breast Cancer
The FDA granted a broader label to Herceptin (trastuzumab), paving the way for Genentech Inc. to promote its most visible targeted oncology product as a front-line treatment for breast cancer.(BioWorld Today)
Read More
British Consolidation: Innovata Bought By Vectura For £131.9M
Read More
Filling The Pipeline: 'Early Stage' Firm Varies In Eyes Of Beholder
Read More
Advanced Magnetics Rises On Positive Phase III Data
Read More
Medicure Starts Pivotal Trial Of MC-1 In Bypass Patients
Read More
Other News To Note
Read More
Clinic Roundup
Read More